VELIPARIB IN COMBINATION WITH CARBOPLATIN FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

• 收藏
• 分享

专利权人:

ABBVIE INC.

发明人:

GORDON, GARY

申请号：

SG11201604658X

公开号：

SG11201604658XA

申请日:

2014.12.10

申请国别(地区):

SG

年份:

2016

代理人:

摘要：

The invention relates to a method for the treatment of triple negative breast cancer in a subject, comprising administering to the subject an effective amount of 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, or a pharmaceutically acceptable salt thereof, and an effective amount of carboplatin, in combination with standard of care.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/